SPP1 and neoplasm: Recently, a study combining spatial transcriptomics and single-cell sequencing showed that in post-treatment samples of individuals who did not benefit from immunotherapy, the mutual interaction between SPP1-positive macrophages and cancer-associated fibroblasts (CAFs) formed the tumor immune barrier (TIB).